相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 T-cell vaccines: evaluating the next step
Giuseppe Pantaleo
LANCET INFECTIOUS DISEASES (2008)
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection
Handan Wand et al.
AIDS (2007)
Portable flanking sequences modulate CTL epitope processing
Sylvie Le Gall et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1
Hamid Hasson et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Interruption of antiretroviral therapy initiated during primary HIV-1 infection:: Impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 randomized study
Cecile Goujard et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Progress towards an AIDS mucosal vaccine: An overview
Yoshikazu Yaki et al.
TUBERCULOSIS (2007)
Current concepts: An HIV vaccine - Evolving concepts
Margaret I. Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
Asier Saez-Cirion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes
Xu G. Yu et al.
JOURNAL OF VIROLOGY (2007)
Virus-epitope vaccine design: Informatic matching the HLA-I polymorphism to the virus genome
Tal Vider-Shalit et al.
MOLECULAR IMMUNOLOGY (2007)
Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction
Tomas Hanke et al.
JOURNAL OF GENERAL VIROLOGY (2007)
CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela et al.
NATURE MEDICINE (2007)
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Will Fischer et al.
NATURE MEDICINE (2007)
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024)
J. Michael Kilby et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic mice
Takahiro Okazaki et al.
JOURNAL OF VIROLOGY (2006)
Mortality in the highly active antiretroviral therapy era - Changing causes of death and disease in the HIV outpatient study
Frank J. Palella et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1:: results of the Staccato randomised trial
Jintanat Ananworanich et al.
LANCET (2006)
Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group M consensus env immunogen
Eric A. Weaver et al.
JOURNAL OF VIROLOGY (2006)
New CD4+ and CD8+T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine
Hanne Gahery et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial):: a randomised trial
Christine Danel et al.
LANCET (2006)
Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults
C Durier et al.
AIDS (2006)
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1
J Martinez-Picado et al.
JOURNAL OF VIROLOGY (2006)
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control
R Zuñiga et al.
JOURNAL OF VIROLOGY (2006)
Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
AMB Kran et al.
AIDS (2006)
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: An adult AIDS clinical trials group study
HJ Ribaudo et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study
C Mussini et al.
AIDS (2005)
Broad cross-glade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): Importance of HLA anchor residue conservation
MJ Geels et al.
JOURNAL OF VIROLOGY (2005)
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection
S Kinloch-de Loes et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
AMB Kran et al.
VACCINE (2005)
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection
F García et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
PB Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Prolonged treatment interruption in chronic HIV infection: a new strategy?
R Giuntini et al.
AIDS (2005)
Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
S Grinspoon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial
F Maggiolo et al.
AIDS (2004)
Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy
A Harari et al.
BLOOD (2004)
Antigen presentation and the role of dendritic cells in HIV
H Donaghy et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2004)
HLA- and dose-dependent immunogenicity of a peptide based HIV-1 immunotherapy candidate (Vacc-4x)
AMB Kran et al.
AIDS (2004)
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
G Pantaleo et al.
NATURE MEDICINE (2004)
Treatment for adult HIV infection - 2004 recommendations of the International AIDS Society-USA panel
PG Yeni et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
W Lu et al.
NATURE MEDICINE (2004)
Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity
C Devito et al.
JOURNAL OF IMMUNOLOGY (2004)
Monitoring of long-term toxicities of HIV treatments: an international perspective
G Bisson et al.
AIDS (2003)
Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach
AS De Groot et al.
VACCINE (2003)
Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals
TF Zhu et al.
JOURNAL OF VIROLOGY (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?
M Youle et al.
AIDS (2003)
Immune tolerance after delivery of dying cells to dendritic cells in situ
K Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination
M Markowitz et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
AIDS - Diversity considerations in HIV-1 vaccine selection
B Gaschen et al.
SCIENCE (2002)
HIV preferentially infects HIV-specific CD4+ T cells
DC Douek et al.
NATURE (2002)
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques
EGT Wee et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Structured treatment interruptions for the management of HIV infection
F Lori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
SG Deeks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Immune restoration and CD4+T-cell function with antiretroviral therapies
MM Lederman
AIDS (2001)
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses
R Kaul et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
SA Migueles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
